PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.

Detalles Bibliográficos
Autores principales: Minarik, L., Stopka, T., Zemanova, Z., Jonasova, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431389/
http://dx.doi.org/10.1097/01.HS9.0000850552.03059.c9
_version_ 1784780042312613888
author Minarik, L.
Stopka, T.
Zemanova, Z.
Jonasova, A.
author_facet Minarik, L.
Stopka, T.
Zemanova, Z.
Jonasova, A.
author_sort Minarik, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9431389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313892022-08-31 PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE. Minarik, L. Stopka, T. Zemanova, Z. Jonasova, A. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431389/ http://dx.doi.org/10.1097/01.HS9.0000850552.03059.c9 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Minarik, L.
Stopka, T.
Zemanova, Z.
Jonasova, A.
PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
title PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
title_full PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
title_fullStr PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
title_full_unstemmed PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
title_short PB1925: VENETOCLAX IN COMBINATION WITH AZACITIDINE OR LOW-DOSE CYTARABINE IN PATIENTS WITH HIGH-RISK MDS AND AML - EXPERIENCE OF A CZECH HAEMATOLOGY CENTRE.
title_sort pb1925: venetoclax in combination with azacitidine or low-dose cytarabine in patients with high-risk mds and aml - experience of a czech haematology centre.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431389/
http://dx.doi.org/10.1097/01.HS9.0000850552.03059.c9
work_keys_str_mv AT minarikl pb1925venetoclaxincombinationwithazacitidineorlowdosecytarabineinpatientswithhighriskmdsandamlexperienceofaczechhaematologycentre
AT stopkat pb1925venetoclaxincombinationwithazacitidineorlowdosecytarabineinpatientswithhighriskmdsandamlexperienceofaczechhaematologycentre
AT zemanovaz pb1925venetoclaxincombinationwithazacitidineorlowdosecytarabineinpatientswithhighriskmdsandamlexperienceofaczechhaematologycentre
AT jonasovaa pb1925venetoclaxincombinationwithazacitidineorlowdosecytarabineinpatientswithhighriskmdsandamlexperienceofaczechhaematologycentre

Ejemplares similares